Biomedix, a leader in advanced diagnostic technology in vascular health, is proud to announce the donation of its cutting-edge PADnet 5th generation device, PADnet Xpress, and accompanying digital health assessments to the New York College of Podiatric Medicine (NYCPM). This donation underscores Biomedix’s commitment to advancing education, clinical research, and Read more…
Biomedix Expands Peripheral Vascular Disease Detection to Mobile Devices Twin Cities, MN — December 4th, 2024 — Today, Biomedix announced the availability of PADnet Xpress for Android devices. PADnet Xpress is the latest edition to the PADnet diagnostic technology designed to identify Peripheral Artery Disease (PAD) in a variety of Read more…
Twin Cities, MN — Biomedix, a pioneer in medical technology and innovation, has announced a clinical and educational sponsorship with the Western University of Health Sciences (WesternU) College of Podiatric Medicine. Established as part of Western University of Health Sciences, the College of Podiatric Medicine is at the forefront of Read more…
HITRUST r2 Certification validates Biomedix is committed to strong cybersecurity and protecting sensitive data. St. Paul MN, September 3rd, 2024 – Biomedix, a leading provider of front-line diagnostic solutions for healthcare organizations, today announced its Biomedix Xchange and PADnet solutions have earned certified status by HITRUST for information security. HITRUST Read more…
Twin Cities, MN— October 5th, 2023 — Biomedix, a market-leading medical technology and innovation company, was invited to screen congressional representatives and their staff at the United States Capitol with PADnet Xpress during the PAD Caucus briefing on September 27th, 2023. PAD Caucus Co-Chairs, Congressman Donald Payne, Jr. and Congressman Read more…
Background: Biomedix is a leading medical device and healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation for care. We are seeking talented individuals to join our sales team in this exciting Read more…
Innovative Leasing Program for MiniOmni Osteoporosis Screening Twin Cities, MN— August 25th, 2023 —Biomedix, a market-leading medical technology and innovation company, and BeamMed, a developer, manufacturer and marketer of best-in-class bone density assessment solutions, announced a new strategic partnership to assist value-based care organizations close OMW and OSW HEDIS gaps. Read more…
Position: Client Support Specialist Background: Biomedix is a leading medical device and healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation for care. We are seeking talented individuals to join our service Read more…
At Biomedix, we strive to promote top-notch vascular care and have compiled the reimbursement rates for PADnet tests, including CPT codes 93922, 93923, and 93924, as well as office visit E/M codes, for the year 2023. Market-by-market data has been gathered and the published Medicare reimbursement rates are available. This Read more…
FDA Clearance For PADnet Xpress For Home Use Twin Cities, MN— November 30th, 2022 — Biomedix, a market-leading medical technology and innovation company, announced that the PADnet Xpress device has received clearance from the FDA for use in the home. “We are excited to announce the expanded clearance for in-home use of Read more…